Publication | Closed Access
An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma.
42
Citations
0
References
2003
Year
Lymphoid NeoplasiaInternational Multi-centreMedicineImmunologyPhase Iii TrialPathologyImmune Checkpoint InhibitorCancer TreatmentCvp ChemotherapyImmunotherapyOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!